StageZero Life Sciences Ltd (SZLS) - Cash Flow Conversion Efficiency

Latest as of September 2024: 0.013x

Based on the latest financial reports, StageZero Life Sciences Ltd (SZLS) has a cash flow conversion efficiency ratio of 0.013x as of September 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-145.57K ≈ $-105.30K USD) by net assets (CA$-11.13 Million ≈ $-8.05 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See SZLS defensive interval ratio to measure how many days the company can operate on defensive assets alone.

StageZero Life Sciences Ltd - Cash Flow Conversion Efficiency Trend (1998–2022)

This chart illustrates how StageZero Life Sciences Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

StageZero Life Sciences Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of StageZero Life Sciences Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Accelerate Resources Ltd AU:AX8	-0.037x
Impera Capital S.A. WAR:IMP	-0.010x
Kandal M Venture Limited Class A Ordinary Shares NASDAQ:FMFC	-0.006x
Global IBO Group Ltd NASDAQ:GIBO	-0.001x
Hiremii Ltd AU:HMI	-0.436x
Montero Mining and Exploration Ltd V:MON	-0.047x
EPRCOMUNICAZIONE S.P.A. F:J3P	N/A
Yari Minerals Ltd AU:YAR	-1.583x

Annual Cash Flow Conversion Efficiency for StageZero Life Sciences Ltd (1998–2022)

The table below shows the annual cash flow conversion efficiency of StageZero Life Sciences Ltd from 1998 to 2022. For the full company profile with market capitalisation and key ratios, see how much is StageZero Life Sciences Ltd worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2022-12-31	CA$-7.50 Million ≈ $-5.43 Million	CA$-3.53 Million ≈ $-2.55 Million	0.470x	+114.50%
2021-12-31	CA$2.76 Million ≈ $2.00 Million	CA$-8.95 Million ≈ $-6.48 Million	-3.242x	-230.51%
2020-12-31	CA$-1.23 Million ≈ $-892.28K	CA$-3.06 Million ≈ $-2.22 Million	2.484x	+143.05%
2019-12-31	CA$-4.49 Million ≈ $-3.25 Million	CA$-4.59 Million ≈ $-3.32 Million	1.022x	+50.23%
2018-12-31	CA$-4.84 Million ≈ $-3.50 Million	CA$-3.29 Million ≈ $-2.38 Million	0.680x	-46.33%
2017-12-31	CA$-3.02 Million ≈ $-2.18 Million	CA$-3.82 Million ≈ $-2.77 Million	1.268x	+62.76%
2016-12-31	CA$-4.73 Million ≈ $-3.42 Million	CA$-3.68 Million ≈ $-2.66 Million	0.779x	-20.01%
2015-12-31	CA$-1.77 Million ≈ $-1.28 Million	CA$-1.73 Million ≈ $-1.25 Million	0.974x	+236.66%
2014-12-31	CA$2.15 Million ≈ $1.56 Million	CA$-1.54 Million ≈ $-1.11 Million	-0.713x	+71.36%
2013-12-31	CA$1.74 Million ≈ $1.26 Million	CA$-4.34 Million ≈ $-3.14 Million	-2.488x	-210.51%
2012-12-31	CA$5.07 Million ≈ $3.67 Million	CA$-4.06 Million ≈ $-2.94 Million	-0.801x	-109.11%
2011-12-31	CA$-321.56K ≈ $-232.61K	CA$-2.83 Million ≈ $-2.05 Million	8.800x	+131.32%
2010-12-31	CA$87.69K ≈ $63.43K	CA$-2.46 Million ≈ $-1.78 Million	-28.100x	-1417.74%
2009-12-31	CA$2.49 Million ≈ $1.80 Million	CA$-4.61 Million ≈ $-3.34 Million	-1.851x	+57.36%
2008-12-31	CA$1.73 Million ≈ $1.25 Million	CA$-7.51 Million ≈ $-5.43 Million	-4.342x	-622.04%
2007-12-31	CA$13.81 Million ≈ $9.99 Million	CA$-8.31 Million ≈ $-6.01 Million	-0.601x	-88.69%
2006-12-31	CA$19.54 Million ≈ $14.13 Million	CA$-6.23 Million ≈ $-4.51 Million	-0.319x	-80.16%
2005-12-31	CA$5.93 Million ≈ $4.29 Million	CA$-1.05 Million ≈ $-758.95K	-0.177x	+45.23%
2004-12-31	CA$7.69 Million ≈ $5.56 Million	CA$-2.48 Million ≈ $-1.80 Million	-0.323x	-294.68%
2003-12-31	CA$5.74 Million ≈ $4.15 Million	CA$-469.80K ≈ $-339.85K	-0.082x	+80.16%
2002-12-31	CA$1.71 Million ≈ $1.24 Million	CA$-707.49K ≈ $-511.78K	-0.413x	+9.50%
2001-12-31	CA$2.29 Million ≈ $1.66 Million	CA$-1.04 Million ≈ $-755.27K	-0.456x	+43.12%
2000-12-31	CA$2.32 Million ≈ $1.68 Million	CA$-1.86 Million ≈ $-1.34 Million	-0.801x	+6.73%
1999-12-31	CA$34.76K ≈ $25.15K	CA$-29.87K ≈ $-21.61K	-0.859x	-2739.35%
1998-12-31	CA$165.36K ≈ $119.62K	CA$-5.00K ≈ $-3.62K	-0.030x	--

About StageZero Life Sciences Ltd

TO:SZLS Canada Diagnostics & Research

Market Cap

$3.58 Million

CA$4.94 Million CAD

Market Cap Rank

#29175 Global

#1376 in Canada

Share Price

CA$0.04

Change (1 day)

+0.00%

52-Week Range

CA$0.04 - CA$0.04

All Time High

CA$4.16